FDA

This Halloween, with much fanfare the FDA and 23AndMe simultaneously announced a new service, genomic testing for an individuals ability to metabolize 50 commonly used prescribed and over the counter medications.

Minneapolis’s Hennepin County Medical Center finds itself in hot water over allegedly systemic practices that, in concert, might have viol

I recently testified to the USDA about food labels for products made using animal cell culture techniques. The testimony is below.

In addition to being a source of universal frustration, the high cost of drugs is a public relations nightmare for health systems and the much maligned pharmaceutical industry.

Like a broken clock that accidentally gets the time right, the State of California has finally stumbled upon the correct approach to coffee. Sort of.

In a story that speaks for itself, King Bio has issued a voluntary nationwide recall out of “an abundance of caution” of thirty-two kids and infant products that could be contaminated

Earlier this month Dr.

The U.S. Court of Appeals for the Federal Circuit just delivered another blow to a rather epic play by pharmaceutical giant Allergan to game the patent system.

In a just published perspective piece in The New England Journal of Medicine, U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, M.D.

Anyone who watches television has seen the ads for Opdivo, Lyrica and countless other drugs directed to consumers (physicians still call these people patients).